MHRA Approves Moderna’s mRNA COVID-19 Vaccine

Medicines and Healthcare products Regulatory Agency (MHRA), the regulator of all medicines and medical devices in the UK has approved Moderna’s COVID-19 vaccine after meeting the required safety, quality and effectiveness standards for use in the UK (1).  

This is the third COVID-19 vaccine to be approved in the UK after Pfizer/BioNTech’s mRNA vaccine BNT162b2 and Oxford/AstraZeneca’s ChAdOx1 nCoV-2019.  

Like Pfizer/BioNTech’s BNT162b2, this vaccine as well is a mRNA vaccine and works on the same principle of injecting viral mRNA in to the cells (2).  

***

Sources:  

  1. MHRA 2021. Press release – Moderna vaccine becomes third COVID-19 vaccine approved by UK regulator. Published 8 January 2021. Available on https://www.gov.uk/government/news/moderna-vaccine-becomes-third-covid-19-vaccine-approved-by-uk-regulator Accessed on 08 January 2021  
  1. Prasad U., 2020. COVID-19 mRNA Vaccine: A Milestone in Science and a Game Changer in Medicine. Scientific European. Posted online on 29 December 2020. Available online on http://scientificeuropean.co.uk/medicine/covid-19-mrna-vaccine-a-milestone-in-science-and-a-game-changer-in-medicine/ Accessed on 08 January 2021.  

***

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Diagnosing Vitamin D Deficiency by Testing Hair Sample Instead of Blood Test

Study shows first step towards developing a test for...

What caused the Mysterious Seismic Waves Recorded in September 2023 

In September 2023, uniform single frequency seismic waves were...

Paride: A novel Virus (Bacteriophage) that fights Antibiotic-tolerant Dormant bacteria  

Bacterial dormancy is survival strategy in response to stressful...

Paradox of Metal-rich Stars in Early Universe  

Study of image taken by the JWST has led...

How Male Octopus Avoid Being Cannibalised by Female  

Researchers have discovered that some male blue-lined octopuses have...

Pandemic Potential of Human Metapneumovirus (hMPV) Outbreaks 

There are reports of outbreaks of Human Metapneumovirus (hMPV)...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...

2 COMMENTS

Comments are closed.